Researchers, Michael J. Fox Foundation Propose New Roadmap for Trials

Researchers, Michael J. Fox Foundation Propose New Roadmap for Trials
A new roadmap for preclinical and clinical trials investigating compounds to treat and prevent Parkinson’s disease was proposed by a team of international academic and industry researchers, the Alpha-Synuclein Clinical Path Working Group, in conjunction with the Michael J. Fox Foundation for Parkinson’s Research. The article, “A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting ... read more
Source: Parkinson’s News TodayPublished on 2019-01-03By Jonathan Grinstein